Neuroinflammation is increasingly recognized as a key factor in the development and progression of a variety of brain disorders. Chronic neuroinflammation contributes to the breakdown of the blood-brain barrier and the accumulation of toxic proteins, leading to neuronal injury and loss. In the context of neuroinflammation and brain disorders, conditions such as Alzheimer's, Parkinson's, and autoimmune diseases like multiple sclerosis are significantly impacted by this inflammatory response. While initially protective, neuroinflammation can become maladaptive, further promoting brain damage. Advances in research are revealing the role of immune cells, such as microglia and T-cells, in driving neuroinflammation and how this process is directly linked to the progression of neuroinflammation and brain disorders. New therapies targeting neuroinflammatory pathways, including anti-inflammatory cytokines and microglial inhibitors, offer potential treatments to mitigate these effects and slow the progression of brain disorders.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States